A total of 73 isolates (57 Enterobacter cloacae and 16 Enterobacter agglomerans), recovered during an outbreak of bacteremia in the Campinas area, São Paulo, Brazil, were studied. Of these isolates, 61 were from parenteral nutrition solutions, 9 from blood cultures, 2 from a sealed bottle of parenteral nutrition solution, and one was of unknown origin. Of the 57 E. cloacae isolates, 54 were biotype 26, two were biotype 66 and one was non-typable. Of 39 E. cloacae isolates submitted to ribotyping, 87.2% showed the same banding pattern after cleavage with EcoRI and BamHI. No important differences were observed in the antimicrobial susceptibility patterns among E. cloacae isolates exhibiting the same biotype, serotype and ribotype. All E. agglomerans isolates, irrespective of their origin, showed same patterns when cleaved with EcoRI and BamHI. The results of this investigation suggest an intrinsic contamination of parenteral nutrition solutions and incriminate these products as a vehicle of infection in this outbreak.
INTRODUCTION
Enterobacter species are emerging as important human pathogens, particularly among hospitalized patients 5, 14, 33, 37 . Among 13 species currently recognized as members of the genus Enterobacter 11, 12 , E. cloacae and E. aerogenes are the most frequently isolated species associated with human diseases 1, 10, 17, 19, 30 . E. agglomerans, commonly found in plants, soil, water and food stuffs, although rarely recognized as an agent of endogenous nosocomial infections 6, 8, 14 , can cause epidemics among hospitalized patients when associated with the use of contaminated intravenous products due to its ability to grow in commercial infusion fluids 22, 23 .
Single source outbreaks of Enterobacter infections have been frequently traced to contaminated intravenous products, blood products, distilled water and pressure monitoring devices 2, 7, 22, 24, 25, 31, 32, 34, 35 . A longlasting epidemic caused by Enterobacter spp involving many hospitals and associated with the use of intrinsically contaminated intravenous solutions was reported in the 1970's in the United States by MAKI et al. 22 .
In March 24, 1997, one hospital of Campinas County, São Paulo State, Brazil, notified the Municipal Secretary of Health of an outbreak of bacteremia associated with intravenous therapy. According to the epidemiological investigation 28 , this outbreak began between 21 and 22 March, and was associated with the use of a parenteral nutrition solution produced by one manufacturer and bearing the same batch number.
Enterobacter cloacae and Enterobacter agglomerans were isolated from in-use infusion bags available in two of eight affected hospitals of Campinas County. Among 49 affected patients of this Municipality, 12 died (two adults and 10 newborns). Bacteremia was the typical clinical manifestation seen in the majority of patients receiving infusion bags after delivered by the manufacturer.
The purpose of this study was to investigate, by phenotypical and genotypic methods, the relatedness of E. cloacae and E. agglomerans strains recovered during this outbreak.
MATERIAL AND METHODS
Bacterial strains. A total of 73 isolates, 57 of them Enterobacter cloacae, and 16 Enterobacter agglomerans, were studied. Of the 57 E. cloacae isolates, 7 were from blood cultures, 48 from solutions administered to patients, one was from a sealed bottle and one was of unknown origin. Concerning the 16 E. agglomerans isolates, 2 were isolated from blood cultures, 13 from solutions administered to patients and one was from a sealed bottle. These isolates were recovered at Instituto Adolfo Lutz, Regional Laboratory, Campinas, in the Department of Clinical Microbiology of Campinas University, UNICAMP, and in the Laboratory of the Hospital "Maternidade de Campinas", Campinas, São Paulo, Brazil. All isolates were recovered in March 1997 during an outbreak of bacteremia that occurred in hospitals using parenteral nutrition solutions produced by one manufacturer. Biochemical identification. All isolates were subjected to biochemical identification 9 , and all E. cloacae were biotyped as previously described 27,36 .
Serotyping. Nineteen E. cloacae isolates were serotyped in the Central Public Health Laboratory, Laboratory of Hospital Infection, Colindale, London, UK. The remaining 38 E. cloacae were serotyped at Instituto Adolfo Lutz, Central Public Health Laboratory, using O-antisera prepared with standard E. cloacae strains received from the Laboratory of Hospital Infection, London, UK. O-serotyping was performed according to methods previously described 15 .
Antibiotic susceptibility testing. The susceptibility of all isolates to antimicrobial agents was determined by the standard disk diffusion method 26 using the following commercial disks (Cecon, Centro de Controle e Produtos para Diagnósticos, S. Paulo, Brazil): amikacin (AM, 30µg), cefoperozone (CPZ, 75µg), cefotaxime (CTX, 30µg), imipenen (IPM, 10µg), ciprofloxacin (CIP, 5µg), tetracyclin (TT, 30µg), chloramphenicol (CLO, 30µg), sulfamethoxazole-trimethoprim (SUT, 1.25/23.75µg), ampicillin (AP, 10µg), cephalotin (CF, 30µg), gentamicin (GN, 10µg), and cephalexin (CX, 30µg).
Ribotyping. All isolates recovered from blood cultures were ribotyped as well as the isolates from sealed bottle. Among isolates from in-use parenteral nutrition solutions we selected at least one isolate of each bottle. Chromosomal DNA of E. cloacae and E. agglomerans was extracted and purified as previously described 3 . DNA samples (3 µg) were cleaved with the restriction enzymes EcoRI and BamHI according to the reaction conditions recommended by the manufacturer (Pharmacia, LKB). DNA fragments were subjected to horizontal electrophoresis in 0.8% agarose (Sigma) in 0.04 M TRIS-acetate and 0.001 M EDTA buffer, and restriction fragments were transferred under vacuum (Vacugene, Pharmacia, LKB) to nylon membranes . The membranes were hybridized with the 16+23S cDNA probe transcribed by reverse transcriptase from E. coli rRNA (Boerhinger Mannheim, Germany) and labelled with digoxigenin according to POPOVIC et al. 29 . A Haemophilus aegyptius (strain # 3031) EcoRI DNA digest (fragment sizes of 1492 ,1713, 3228, 3789, 4960, 5575, 6334, and 17613 bp) was used as molecular marker. Fragment sizes were estimated with a computer program (DNASTAR Computer System for Molecular Biology and Genetics, London, UK).
RESULTS
Biotyping and serotyping. Of E. cloacae isolates 39 were assigned to biotype 26 / serotype O3, 13 to biotype 26 / OR ( rough ), four belonged to other biotypes / serotypes and one was non-typable by biotyping or serotyping. The characteristics of all strains are summarized in Table 1 .
Antimicrobial susceptibility patterns. The majority of E. cloacae showed no important differences in the antimicrobial susceptibility patterns, being homogeneously resistant to ampicillin, cephalothin, cephalexin, and gentamicin. One isolate of biotype 26 / O19 and one of biotype 66 / NT were resistant to 9 drugs. Of 16 E. agglomerans isolates, 13 were susceptible to all tested drugs, 2 were resistant to ampicillin, gentamicin and tetracycline and one was resistant to ampicillin, gentamicin, tetracycline, amikacin and chloramphenicol.
Ribotyping. DNA samples of 39 E. cloacae and 15 E. agglomerans were digested with EcoRI and BamHI. All 34 E. cloacae isolates belonging to biotype 26 and to serotype O3 or OR (rough isolates), irrespective of their origin (solution administered to patients, sealed bottle of parenteral nutrition solution and blood cultures) were homogeneously cleaved with Eco RI, generating 16 fragments ranging in size from 1.3 to 22.9 kp, and were assigned to pattern E1. These 34 isolates, which also showed a unique pattern (B1) with 8 bands ranging in size from 6.0 to 25.8 kp when cleaved with BamHI, were assigned to ribotype E1B1. DNA sample (extraction was repeated twice) of one E. cloacae isolate (biotype 26 / serotype O14) was sheared and was not digested. E. cloacae isolates belonging to biotype 26 / serotype O19 (one isolate), biotype 66 / NT (two isolates) and NT / NT (one isolate) displayed patterns distinct from E1B1 when cleaved with EcoRI or BamHI and were classified as ribotypes E2B2, E3B3, E4B4, and E5B5, respectively. All E. agglomerans isolates when cleaved with EcoRI showed a unique pattern (E6) with 12 fragments ranging from 1.7 to 14.5 kp. The homogeneity of these isolates was confirmed with the second enzyme BamHI. All E. agglomerans isolates were classified as ribotype E6B6. Figure 1 shows the banding patterns of E. cloacae and E. agglomerans recovered from solutions administered to patients, from blood cultures and from one sealed bottle of parenteral nutrition solution, after digestion with EcoRI and BamHI, respectively. Schematic representation of the banding patterns of ribotypes of E. cloacae and E. agglomerans is shown in Figure 2 . 
DISCUSSION
Phenotypic methods when used in combination could be sufficiently discriminatory and satisfactory to differentiate the majority of clinical isolates of E. cloacae 13, 36 . Using conventional typing methods, we could differentiate a main group of 39 E. cloacae represented by isolates characterized as biotype 26 / serotype O3. E. cloacae serotype O3 strains are the most frequently isolated serotype from human infections 16, 36 and are probably widely disseminated in the environment.
This group of phenotypically similar isolates was genetically homogeneous as determined by ribotyping. On the other hand, four isolates which belonged to distinct biotypes and serotypes were also heterogeneous when assayed by ribotyping.
Biochemical and genotypic similarities shared by E. cloacae isolated from a sealed bottle of parenteral nutrition solution and E. cloacae isolated from solutions administered to patients point to the intrinsic contamination of these solutions, probably from environmental origin because of the antimicrobial susceptibilty pattern. Extrinsic contamination of the solutions administered to patients is unlikely, considering that nocomial strains of E. cloacae are usually multiresistant.
Multiple resistant E. cloacae strains belonging to some biotypes such as biotype 26 and 66 are frequently associated with human infections probably because these strains are present in some hospital units such as intensive care units 37 . It was not surprising that such nosocomial pathogens could be isolated from some infusion bottles as was seen with Patient 7, where in addition to the intrinsic contamination, an extrinsic contamination by multiple resistant nosocomial E. cloacae (biotype 66 / NT and ribotype E4B4) problably occurred. An extrinsic contamination was also suspected in an infusion bottle administered to Patient 8 from which it was isolated a multiple resistant E. cloacae strain belonging to biotype 26 / serotype O19, and ribotype E2B2.
The high genetic heterogeneity of E. agglomerans 4, 20, 21 makes it difficult to establish a satisfactory system for its identification. According to FARMER 11 , only cultures that are yellow pigmented and triple decarboxylase-negative strains are usually identified as E. agglomerans. All of our isolates that were triple decarboxylase-negative, although none was yellow pigmented, were identified as E. agglomerans. The lack of phenotypic methods to discriminate strains and to support similarities among strains of E. agglomerans is a drawback in epidemiological studies. In this study the relatedness of E. agglomerans strains isolated from solutions administered to patients, from blood cultures and from a sealed bottle of parenteral nutrition solution could be only confirmed by ribotyping. Both EcoRI and BamHI provided a precise evidence of strains relatedness.
Ribotyping proved to be an extremely useful method to confirm the identity of our isolates as other investigators had already reported 13, 18, 35, 38 . In our sample, most of E. cloacae isolates were assigned to the same ribotype (E1B1) which assesses the genetic similarity of the isolates of the main group identified as biotype 26/serotype O3 or 26/OR of distinct origins.
Our results suggest that E. cloacae and E. agglomerans were present in the solutions when they were delivered to the hospitals (intrinsic contamination) since at least one of the two microorganisms present in a sealed bottle was isolated from the solutions administered to 26 patients. On the other hand, recovery of the same microorganisms from blood cultures of patients using these solutions incriminates them as a vehicle of transmission of these agents during the outbreak. 
